Improved guidance and a big contract attracted investors to the dialysis equipment company.
Little-known Boston Omaha is a quiet compounder, while Outset Medical's dialysis treatment could change millions of lives.
SAN JOSE, Calif.--( BUSINESS WIRE )--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialy
Outset Medical, Inc. revised FY22 guidance to the upside, with management forecasts now ahead of consensus. Home hemodialysis market is poised for ongoing growth into 2028.
These companies are disrupting the healthcare industry and growing rapidly.
Outset Medical, Inc. (NASDAQ:OM ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Jim Mazzola – Vice President-Investor Relations Leslie Trigg – Chair and Chief E
Outset Medical continued to face a multivariate equation of headwinds last quarter. The stock has continued its long-term downtrend whilst technical indicators aren't signalling a reversal any time so
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi
Outset Medical, Inc. (NASDAQ:OM ) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Company Participants Jim Mazzola - Vice President Investor Relations Leslie Trigg - Chair & Chief Executive
A major FDA decision clears the way for Outset to again go after a huge opportunity.
Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -22.22% and 2.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The mean of analysts' price targets for Outset Medical, Inc. (OM) points to a 93.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo
Medical Info Systems stocks like Omnicell, Inc. (OMCL), Axonics, Inc. (AXNX) and Outset Medical, Inc. (OM) are expected to gain despite pandemic-led disruptions.
The temporary issue could present a great buying opportunity for long-term investors.
Outset Medical Inc (NASDAQ: OM) implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the FDA review and clearance of a 510(k). The company submitted
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE